Cerulea Clinical Trials

Close Menu
Close Close

Delivering excellence in ophthalmic clinical trials

Putting new therapies in sight

We are a trusted partner delivering the best clinical trial experience for participants, clinicians and sponsors. Our experienced team delivers Phase I-IV trials with specialist capabilities in glaucoma and retinal diseases, gene and cell therapies and medical devices.

Register your interest

Take part in research
Help shape the future of vision research by taking part in a clinical trial. Access the newest therapies, receive the best clinical care and support medical research.

About us

Trusted research partners
Cerulea Clinical Trials is a not-for-profit ophthalmic clinical trials site committed to a world free from vision loss and blindness.  

Collaborate with us

Current trials
Explore our list of current industry-sponsored clinical trials and investigator-initiated clinical research.

Introducing Cerulea Clinical Trials

In this video, meet the team behind Cerulea Clinical Trials, learn about the opportunities ahead in ophthalmic clinical trials and hear from the participants involved in our research.

Watch the video

Latest News

New centre to boost access to sight-saving therapies

02 April 2025

Cerulea Clinical Trials, launched today in Melbourne, will bring more international trials to Victoria and give people living with vision loss and blindness early access to sight-saving therapies.
News

Clinical trials innovator to lead eye trial centre

18 December 2023

Clinical trials innovator and digital health expert Michelle Gallaher has been appointed the inaugural CEO of Cerulea, a new clinical trial centre to be established by the Centre for Eye Research Australia.
News

Transforming clinical trials

28 September 2023

Work is underway on a new state-of-the-art clinical trial centre that will give more people the chance to take part in research.
News

$10m kickstart for sight-saving eye clinical trials centre

06 June 2023

A new world-leading eye clinical trials centre will give Victorians facing vision loss and blindness greater access to innovative, sight-saving treatments.